Search

The article reports on the finding by patent judges of the U.S. International Trade Commission (ITC) that Apple is guilty of appropriating innovations in smartphones, semiconductors and smartwatches and their demand for Apple to remove a health feature from Apple Watches. Topics include the campaign by the company for legislation that would make some patent owners ineligible to bring complaints before the ITC and comments from patent law expert Adam Mossoff.

The article reports on the patent manipulation of the anti-inflammatory drug Humira from AbbVie that made the drug company 114 billion dollars in revenue. It discusses the patent strategy of AbbVie and its building of intellectual property protection for Humira that made it difficult for biosimilars to follow behind. Issues regarding the high price of Humira and the out-of-pocket costs paid by an average Medicare patient are discussed.

The article reports on the patent control issues in the effective production of Covid-19 vaccines to allow the vaccination of people in poor countries as of March 2021. Also cited are how Western governments like the U.S., Great Britain, and the European Union (EU) successfully partnered with drugmakers to develop vaccines, and the move by leaders like U.S. President Joe Biden and the EU's Ursula von der Leyen to focus at home first before sharing their vaccines.

The article focuses on a federal jury ruling that the U.S. government does not have an ownership claim to lucrative Human Immunodeficiency Virus prevention drugs sold by Gilead Sciences. Topics include the defeat for the government and activists pushing for more financial and legal rights to publicly funded medicines, the history of the development of Truvada and Descovy drugs, and the government's argument that Gilead violated patents but the jury ruling in favor of Gilead.

The article reports on the dispute between Moderna and the U.S. National Institute of Health (NIH) on the issue of who should be credited for inventing the key ingredient of the Moderna coronavirus vaccine. According to the NIH, the vaccine should be called "NIH-Moderna Covid-19 vaccine" due to the participation of its staff in its development. Moderna, however, claimed that only its employees invented the vaccine based on its filing with the Patent and Trademark Office.

The article details the national federation of panela producers Fedepanela's opposition against the patent for the panela product Policane, which was applied by Riopaila Castilla's shareholder Jorge González Ulloa in Colombia. Topics mentioned include the importance of panela production to the country's rural economy, the similarity between the method of producing Policane and the country's traditional panela, and the criticism on the patent awarded by the U.S. Patent and Trademark Office.

The article reports on the lawsuit filed by the U.S. Department of Health and Human Services against drug maker Gilead Sciences in November 2019 due to its alleged infringement of government patents on the concept of preventing human immunodeficiency viruses (HIV) with a daily pill. Other topics include the goal by the administration of President Donald Trump to stop the AIDS epidemic by 2030, and the defense of Gilead that the patents are invalid.

Reports on the increased competition facing toy plastic building block maker, Lego Group of Denmark. Expiration of the patent for Lego; Efforts of Lego Group to guard its trademarks and other intellectual property rights; Lawsuits filed by Lego against its competitors, such as Mega Bloks of Montreal; Mega Blok's move in 1994 into the European market.

Reports that a U.S. federal court invalidated a patent of Merck & Co. Inc.'s Fosamax brand of osteoporosis treatment, and the firm's second best-selling drug in January 2005. Opening of the Fosamax formulation to generic competition in 2008; Sales performance of Fosamax.

Cites the deal between Dow Chemical and Dendritic Nanotechnologis requiring Dow to turnover its portfolio of patents for a family of dendritic polymers in exchange for a approximately 30 percent in Dendritic.

Reports on a decree issued by the Indian government to bring its patent laws into compliance with the requirements of the World Trade Organization (WTO). Delay of patent reform because of political concerns that an overhaul would result in higher drug prices; Goal of spurring innovative drug companies to switch from making generic drugs.

Reports that Acacia Research has agreed to buy Global Patent Holdings. Goal of the company in buying Global Patent Holdings, according to CEO Paul R. Ryan.

Focuses on the decline in the quality of patents that are being awarded to Americans. Description of the American government's efforts in encouraging universities to take a larger role in maintaining American economic competitiveness; Reasons for broadening the academic mission.

Presents a correction to the article about the rising number of patent lawsuits by Japanese companies that was previously published in the World Business section of the December 3, 2004 issue of the “New York Times” newspaper.

Reports that an anonymous bidder has acquired a set of patents covering key aspects of commercial Internet transactions auctioned as part of the bankruptcy of Commerce One Inc.

Reports on the emergence of free riding on the Internet such as online music and film swapping. Claim that free riding is not limited to cultural products it also evident in prescription medications; Consequences of the free flow of intellectual property; Suggestion that the growth of drug importation, index investing and Intent music sharing will be an economic problem of the digital age.

Reports on how to reduce the cost of prescription drugs in the United States. Disadvantages of patent protection; Suggestion that the government could compensate drug companies for their discoveries as an incentive for them to keep innovating; Outlook for the cost of prescription drugs.

Reports on the settlement of a patent infringement lawsuit between Eastman Kodak and Sun Microsystems.

Reports on the U.S. Patent and Trademark Office ruling on a patent lawsuit between the developer of engineered crops, Monsanto Co., the Max Planck Institute and other groups in the industry over the use of a technology to modify genes in plants like cotton. Details about the ruling in favor of Monsanto Co.; Operations and technologies developed by Monsanto.

Reports that Qualcomm, the world's second-largest maker of chips that power mobile telephones, will buy Iridigm Display Corp. for $170 million to acquire its patented technology for cellphone screens.

Focuses on the U.S. Patent Office's granting of patent to Xavier University pharmacy professor Susan Perry Hinton for a personal bathroom seat. Emphasis on hygiene; Settings of the legs; Enumeration of toilet innovators granted with patents.

Reports on the decision of pharmaceutical company, GlaxoSmithKline PLC, to give up the fight to protect a patent for its diabetes medication in China.

Focuses on Acacia Research Corp., a company in Newport Beach, California that claims to be owed royalties on much of the Internet's medial content. Letters sent by the company demanding licensing fees from the online pornography industry and from educational organizations that offer Web-based classes; Lawsuit filed by a group of pornography companies against Acacia; Victory of companies that refused to pay any royalties to Acacia for its V-chip patent.

Reports on the announcement of Google Corp. that it had settled a patent dispute with its archrival Yahoo! Inc. Impact of the settlement on the uncertainty surrounding Google's business as it prepares for the public auction of its stock; Delay of Google's initial public offering.

Relates developments regarding the X-patents, U.S. patents issued from July 1790 to July 1836 which were burned in a fire. Recovery of only 2,800 out of the 10,000 patents estimated to be lost; Discovery of several important patents from the 1790s by two lawyers.

Presents a corrected version of the an article in the Patents column about an idea for a car that appears to express emotion, which was previously published in the July 26, 2004 issue of the newspaper.

Reports that inventors working for Toyota in Japan have won a patent for car that they say can help drivers communicate better by glaring angrily at another car cutting through traffic as well as appear to cry, laugh, wink or just look around. Features of the car including an antenna that wags, an adjustable body height, headlights that vary in intensity and hood slits and ornamentation designed to look like eyebrows, eyelids and tears; Inclusion of a computer and software system in the car that detects road and vehicle conditions; Patent inclusion of a chart that shows how the car might display emotions.

Reports that Whitehouse Station, New Jersey-based drug maker Merck & Co. has announced that the European Patent Office has revoked its patent for a once-weekly version of the bone-loss treatment Fosamax. Plan to appeal; Goal of the patent to protect Fosamax from generic competition until 2018.

Focuses on a gas mask developed and patented by Boris Altshuler and James F. Reynolds of CR Clean Air Technologies in Westfield, New Jersey. Creation of a version of a supplied-air respirator; Mask's reliance on activated carbon, which filters contaminated air; Immediate removal from the area that is contaminated; Description of other gas masks on the market.

Presents a correction to an article about Internet-related patents.

Reports that GlaxoSmithKline has agreed to pay $92 million to settle lawsuits related to the company's alleged misuse of patents to thwart generic competition to the antibiotic Augmentin. Amount to be paid to wholesalers and other direct purchasers; Plan to take a charge of 170 million British pounds in the second quarter to settle the lawsuits.

Reports that Donald R. Hall has received a wide-ranging U.S. patent covering several approaches that might help control mosquito populations across wide areas such as wetlands or regions in Africa where mosquito-borne illnesses are rampant. Description of Hall's inventions that kills mosquito eggs; Description of how the devices kills mosquito eggs; Price range of Hall's inventions.

Reports on a coalition of lawyers, researchers and software experts formed by the Electronic Frontier Foundation which will try to overturn 10 Internet and software-related patents in the U.S. that the group claims is threatening innovation. Promotion of digital civil rights; Goal of finding evidence that other companies had already developed the concepts covered by the patent.

Reports that inventors at AOL TV in Virginia won a patent for software that allows people to log on to Instant Messaging or chat rooms and see that television shows their friends or even strangers are watching. Software development; Control of which chat rooms the user visits; Lag to keep the system from switching if a user is just channel surfing.

The article focuses on the U.S. President Joe Biden's about-face on pushing pharmaceutical companies to share vaccine patents, in an attempt to help poorer countries, faces a considerable challenge in Europe.

The article offers information on the impact of control of seed business among big seed companies on the food industry in the U.S. Topics discussed include distribution, processing and marketing of seeds; scope of utility patents has expanded to include novel plant traits and increase in different varieties of vegetables; and advances in organic vegetable industry.

The article focuses on rising urge to suspend intellectual property protections from COVID-19 drugs, vaccines and diagnostic technologies to ensure fair distribution; and mentions planning of pharmaceutical companies in India and South Africa to work with local partners to make vaccines available.

The article reports on several patent applications filed by technology companies Amazon and Google in 2018. Amazon identified a voice sniffer algorithm that could be used on an array of devices. Amazon filed a number of patent applications that explore the full possibilities of new technologies such as devices that record and process audio only.

The article provides information on business concerns related to patents and working criteria of Eastman Kodak Co. Topics discussed include merger and acquisition of its patents, bankruptcy filed in 2012 and involvement of investors in gambling, immutable records kept in ownerships, and probable growth through cryptocurrency.

The article discusses the crisis phase faced by Teva Pharmaceutical Industries the generic drug manufacturing company in Israel. It outlines the decline of the company from a successful position to a disastrous condition with loss of patents, decreasing price of drugs, job slashes, and suspended dividends. It talks about the protests and strikes going on in the country due to this. It also discusses the Israeli Prime Minister Benjamin Netanyahu regarding this.

The article reports on the issue of the resurgence of bad patents in the U.S. Topics discussed include incidents involving the scheme using patents to extract royalties to small businesses, and presents the case pertaining to inappropriate use of bad patents including the alleged selling rights scheme of Teva Pharmaceutical for its multiple sclerosis drug. Also mentioned is the initiative to improve patent law in the country which seek to prevent bad patents in the market.